Matches in Wikidata for { <http://www.wikidata.org/entity/Q91029212> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q91029212 description "article scientifique publié en 2019" @default.
- Q91029212 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q91029212 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91029212 description "scientific article published on 09 January 2019" @default.
- Q91029212 description "wetenschappelijk artikel" @default.
- Q91029212 description "наукова стаття, опублікована 9 січня 2019" @default.
- Q91029212 name "Assessment of doxorubicin delivery devices based on tailored bare polycaprolactone against glioblastoma" @default.
- Q91029212 name "Assessment of doxorubicin delivery devices based on tailored bare polycaprolactone against glioblastoma" @default.
- Q91029212 type Item @default.
- Q91029212 label "Assessment of doxorubicin delivery devices based on tailored bare polycaprolactone against glioblastoma" @default.
- Q91029212 label "Assessment of doxorubicin delivery devices based on tailored bare polycaprolactone against glioblastoma" @default.
- Q91029212 prefLabel "Assessment of doxorubicin delivery devices based on tailored bare polycaprolactone against glioblastoma" @default.
- Q91029212 prefLabel "Assessment of doxorubicin delivery devices based on tailored bare polycaprolactone against glioblastoma" @default.
- Q91029212 P1433 Q91029212-55B048D3-0EEC-4346-BFAB-565EE627BDD7 @default.
- Q91029212 P1476 Q91029212-108FBE7D-26DD-499D-AAE6-1A762459D885 @default.
- Q91029212 P2093 Q91029212-2D51D691-A4F3-48D9-AD40-5DE82AE0ED79 @default.
- Q91029212 P2093 Q91029212-3593266C-8ACE-4C88-AB29-B256093F712A @default.
- Q91029212 P2093 Q91029212-A6F89111-50CD-468F-9851-BFC0EA73738B @default.
- Q91029212 P2093 Q91029212-D0E4089A-D1FD-4B28-B271-DAAD49DE8500 @default.
- Q91029212 P2093 Q91029212-E1512BFB-82C9-4394-834C-8D2E8F0BD071 @default.
- Q91029212 P2093 Q91029212-E1973BE8-858E-478F-9959-D112654659F2 @default.
- Q91029212 P2093 Q91029212-FC61D68B-C57E-4853-BA2B-E84FF38DBFC3 @default.
- Q91029212 P304 Q91029212-20E31D20-E291-4F90-AFED-97AE2BD33093 @default.
- Q91029212 P31 Q91029212-456CF67B-98E6-4A93-8342-074F588BAEB2 @default.
- Q91029212 P356 Q91029212-CA006BBD-AD11-4E47-843D-9DA17CCB49AA @default.
- Q91029212 P478 Q91029212-8022FAA9-2280-4439-9B35-1234D4A130D0 @default.
- Q91029212 P50 Q91029212-0CC9B445-6BE2-4FAC-A6B6-D0F66F3F148B @default.
- Q91029212 P50 Q91029212-9A9F474A-65B7-4888-B9B9-896785A7DA39 @default.
- Q91029212 P50 Q91029212-A0D2D10C-BB9E-4995-B294-3326A759D977 @default.
- Q91029212 P50 Q91029212-C710DBA2-E3FB-49CE-B237-9C8A592E244A @default.
- Q91029212 P577 Q91029212-577E6890-9494-4D64-ACF1-D21134F1BCAA @default.
- Q91029212 P698 Q91029212-98702A56-37FB-477E-831D-EC742A0A0F02 @default.
- Q91029212 P921 Q91029212-A634BA23-9C36-4566-8434-0DB807B3163C @default.
- Q91029212 P921 Q91029212-E9FDE979-EEA1-40A2-815B-BCC18E629111 @default.
- Q91029212 P356 J.IJPHARM.2018.12.079 @default.
- Q91029212 P698 30639216 @default.
- Q91029212 P1433 Q6051539 @default.
- Q91029212 P1476 "Assessment of doxorubicin delivery devices based on tailored bare polycaprolactone against glioblastoma" @default.
- Q91029212 P2093 "Andrés Garzón" @default.
- Q91029212 P2093 "Antonio Otero" @default.
- Q91029212 P2093 "Enrique Niza" @default.
- Q91029212 P2093 "Inmaculada Posadas" @default.
- Q91029212 P2093 "Iván Bravo" @default.
- Q91029212 P2093 "José A Castro-Osma" @default.
- Q91029212 P2093 "José Albaladejo" @default.
- Q91029212 P304 "110-119" @default.
- Q91029212 P31 Q13442814 @default.
- Q91029212 P356 "10.1016/J.IJPHARM.2018.12.079" @default.
- Q91029212 P478 "558" @default.
- Q91029212 P50 Q37828622 @default.
- Q91029212 P50 Q75399019 @default.
- Q91029212 P50 Q79987645 @default.
- Q91029212 P50 Q80578804 @default.
- Q91029212 P577 "2019-01-09T00:00:00Z" @default.
- Q91029212 P698 "30639216" @default.
- Q91029212 P921 Q18936 @default.
- Q91029212 P921 Q282142 @default.